1. S. Budavari (Ed.), The Merck Index, Merck and Co., Whitehouse Station, NJ, 12th ed., 1996, p. 1374.
2. USP DI, Drug Information for the Health Care Professional, United States Pharmacopeial Convention, 17th ed., 1997, pp. 2486–2487.
3. USP DI, Drug Information for the Health Care Professional, United States Pharmacopeial Convention, 17th ed., 1997, pp. 937–941, 945, 955–956.
4. H.C. Korting, H.I. Maibach (Eds.), Topical Glucocorticoids with Increased Benefit/Risk Ratio, Karger, Basel, 1993, pp. 6–8, 122–125, 192.
5. Netherlands Ministry of Health, Welfare and Sports, The Hague, personal communication.